Checklist in conjunction with the Summary of Product Characteristics during combined hormonal contraceptive (CHC) consultations.

Important information for women about risk of blood clots with combined hormonal contraceptives (CHC).

This patient booklet contains important things to remember about Gilenya (fingolimod) treatment for patients, parents and caregivers

This reminder card contains pregnancy-specific safety information about Gilenya (fingolimod) treatment

This checklist outlines important points to remember before, during and after treatment

This Pharmacy Checklist is designed to support you during consultations with women who are requesting Gina. It provides questions for your customer to answer in order for you to check their suitability for Gina and determine which action to take each visit.

This guide, along with the Pharmacy Checklist, is part of a package of materials that Novo Nordisk has put in place to support the launch of Gina (estradiol hemihydrate 10 micrograms) as a Pharmacy medicine for the treatment of vaginal atrophy. It summarises key information to help you identify postmenopausal women to whom you can supply Gina, and the advice you should give to help them use Gina appropriately.

Checklist for assessment of anticholinergic effects table. Important information to be brought to the attention of the parent/caregiver. Additional points to emphasise.

How to manage common side effects. Important information on the administration of Glycopyrronium Bromide 1 mg/5 ml Oral Solution. Dose administration table to be completed by the doctor. How to manage important side effects. Additional information.

The healthcare professional (HCP) checklist is an aid to help you evaluate and discuss the risks associated with glycopyrronium bromide tablets with the patient’s carer. It provides important information on the management and minimisation of side effects.

This patient alert card is an aid which helps to provide the patient’s caregiver with essential information on the administration of glycopyrronium bromide tablets and the management and minimisation of side effects. It is important that this card is given to the treating doctor to record guidance on dosing.

The patient alert card is an aid which helps to provide the patient’s caregiver with essential information on the administration of Glycopyrronium bromide tablets and the management and minimisation of side effects. It is important that this card is given to the treating doctor to record guidance on dosing.

The healthcare professional (HCP) checklist is an aid to help you evaluate and discuss the risks associated with glycopyrronium bromide tablets with the patient’s carer. It provides important information on the management and minimisation of side effect.

These educational materials focus on the provision of advice for the recognition of anticholinergic effects that can be associated with glycopyrronium bromide containing products and how best to manage specific events.

These educational materials focus on the provision of advice for the recognition of anticholinergic effects that can be associated with glycopyrronium bromide containing products and how best to manage specific events.

The healthcare professional (HCP) checklist is an aid to help you evaluate and discuss the risks associated with glycopyrronium bromide oral solution with the patient’s carer. It provides important information on the management and minimisation of side effects.

"The healthcare professional (HCP) checklist is an aid to help you evaluate and discuss the risks associated with glycopyrronium bromide tablets with the patient’s carer. It provides important information on the management and minimisation of side effects."

"This patient alert card is an aid which helps to provide the patient’s caregiver with essential information on the administration of glycopyrronium bromide tablets and the management and minimisation of side effects."

This patient alert card is an aid that helps to provide the patient’s caregiver with essential information on the administration of glycopyrronium bromide oral solution and the management and minimisation of side effects. This card must be given to the treating doctor to record guidance on dosing